The 25-hydroxyvitamin D3 C-3 epimer: Distribution, correlates, and reclassification of 25-hydroxyvitamin D status in the population-based Atherosclerosis Risk in Communities Study (ARIC)

被引:41
作者
Lutsey, Pamela L. [1 ]
Eckfeldt, John H. [2 ]
Ogagarue, Ejovvvoke R. [3 ]
Folsom, Aaron R. [1 ]
Michos, Erin D. [4 ]
Gross, Myron [2 ]
机构
[1] Univ Minnesota, Div Epidemiol & Community Hlth, Minneapolis, MN 55454 USA
[2] Univ Minnesota, Dept Lab Med & Pathol, Minneapolis, MN 55455 USA
[3] Univ Minnesota, Dept Urol, Minneapolis, MN 55454 USA
[4] Johns Hopkins Sch Med, Div Cardiol, Baltimore, MD USA
关键词
25-Hydroxyvitamin D-3 C-3 epimer; Vitamin D; Race; Reclassification; Atherosclerosis Risk in Communities Study (ARIC); VITAMIN-D; ENZYMATIC DETERMINATION; POTENT SUPPRESSOR; SERUM; INFANTS; CHOLESTEROL; METABOLITES; REAGENT; PLASMA;
D O I
10.1016/j.cca.2014.12.036
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Background: Little is known about the vitamin D3 epimer [3-epi-25(OH)D3], particularly in adults. We describe characteristics of the D3 epimer within the community-based ARIC cohort. Methods: The vitamin D3 epimer, 25(OH)D-3, and 25(OH)D-2 were measured using LC-MS/MS in stored serum collected in 1990-1992 from 9,887 white and 3,221 black ARIC study participants, aged 46-70 years. Cross-sectional characteristics were explored. Results: Concentrations of the epimer were quantifiable (>= 1.41 ng/ml) in 33.4% of whites and 15.0% of blacks and made up on average 3.23% and 2.25% of total D3 [epimer + 25(OH)D-3] concentrations, respectively. Epimer levels were positively correlated with 25(OH)D-3 in both whites (r = 0.54) and blacks (r = 036) and were unrelated to 25(OH)D-2 concentrations. Overall, epimer levels were associated with participant characteristics in a manner similar to that typically observed for 25(OH)D-3. Including the epimer in the calculation of total 25(OH)D resulted in approximately 2% of participants being reclassified from being clinically 25(OH)D deficient to having suboptimal levels. Conclusions: Low concentrations of the D3 epimer were present in adult serum and overall the epimer concentration is moderately correlated with the 25(OH)D-3 concentration. The reclassification of participant's clinical 25(OH)D status upon inclusion of the epimer was minimal. (C) 2015 Elsevier B.V. All rights reserved.
引用
收藏
页码:75 / 81
页数:7
相关论文
共 33 条
[1]   1α25-dihydroxy-3-epi-vitamin D3 a physiological metabolite of 1α,25-dihydroxyvitamin D3:: Its production and metabolism in primary human keratinocytes [J].
Astecker, N ;
Reddy, GS ;
Herzig, G ;
Vorisek, G ;
Schuster, I .
MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2000, 170 (1-2) :91-101
[2]   Simultaneous quantification of four vitamin D metabolites in human serum using high performance liquid chromatography tandem mass spectrometry for vitamin D profiling [J].
Baecher, Silvia ;
Leinenbach, Andreas ;
Wright, Jo Anne ;
Pongratz, Stephan ;
Kobold, Uwe ;
Thiele, Roland .
CLINICAL BIOCHEMISTRY, 2012, 45 (16-17) :1491-1496
[3]  
BAECKE JAH, 1982, AM J CLIN NUTR, V36, P936
[4]   Analytical measurement and clinical relevance of vitamin D3 C3-epimer [J].
Bailey, Dana ;
Veljkovic, Kika ;
Yazdanpanah, Mehrdad ;
Adeli, Khosrow .
CLINICAL BIOCHEMISTRY, 2013, 46 (03) :190-196
[5]   Racial and seasonal differences in 25-hydroxyvitamin D detected in maternal sera frozen for over 40 years [J].
Bodnar, Lisa M. ;
Catov, Janet M. ;
Wisner, Katherine L. ;
Klebanoff, Mark A. .
BRITISH JOURNAL OF NUTRITION, 2009, 101 (02) :278-284
[6]   The effect of vitamin D supplementation on skeletal, vascular, or cancer outcomes: a trial sequential meta-analysis [J].
Bolland, Mark J. ;
Grey, Andrew ;
Gamble, Greg D. ;
Reid, Ian R. .
LANCET DIABETES & ENDOCRINOLOGY, 2014, 2 (04) :307-320
[7]   Isolation and identification of 1α-hydroxy-3-epi-vitamin D3, a potent suppressor of parathyroid hormone secretion [J].
Brown, AJ ;
Ritter, CS ;
Weiskopf, AS ;
Vouros, P ;
Sasso, GJ ;
Uskokovic, MR ;
Wang, GC ;
Reddy, GS .
JOURNAL OF CELLULAR BIOCHEMISTRY, 2005, 96 (03) :569-578
[8]  
Brown AJ, 1999, J CELL BIOCHEM, V73, P106, DOI 10.1002/(SICI)1097-4644(19990401)73:1<106::AID-JCB12>3.0.CO
[9]  
2-Q
[10]  
Byrd-Bredbenner C.B., 2013, WARDLAWS PERSPECTIVE